Drug-related admissions and hospital-acquired adverse drug events in Germany: A longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Stausberg, Jürgen ^a   Hasford, Joerg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG TOXICITY; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; LONGITUDINAL STUDY; MALE; MEDICATION ERROR; MIDDLE AGED; RISK ASSESSMENT; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG TOXICITY; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; IATROGENIC DISEASE; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MEDICATION ERRORS; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 79957471572     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-134     Document Type: Article

References (47)

1. Adverse drug reaction monitoring - cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admission. N Muehlberger S Schneeweiss J Hasford, Pharmacoepidemiol Drug Saf 1997 6 Suppl 3 71 77 15073757
2. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Lazarou BH Pomeranz PN Corey, JAMA 1998 279 1200 1205 10.1001/jama.279.15.1200 9555760 (Pubitemid 28193431)
3. Adverse drug reactions as cause of admission to hospital: a prospective analysis of 18820 patients. M Pirmohamed S James S Meakin C Green AK Scott TJ Walley K Farrar BK Park AM Brickenridge, BMJ 2004 329 15 19 10.1136/bmj.329. 7456.15 15231615 (Pubitemid 38869995)
4. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. C Kongkaew PR Noyce DM Ashcroft, Ann Pharmacother 2008 42 1017 1025 10.1345/aph.1L037 18594048
5. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. EC Davies CF Green S Taylor PR Williamson DR Mottram M Pirmohamed, PLoS ONE 2009 4 4439 10.1371/journal.pone.0004439 19209224
6. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. S Schneeweiss J Hasford M Göttler A Hoffmann AK Riethling J Avorin, Eur J Clin Pharmacol 2002 58 285 291 10.1007/s00228-002-0467-0 12136375 (Pubitemid 34827858)
7. Adverse drug reaction monitoring - cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. M Goettler S Schneeweiss J Hasford, Pharmacoepidemiol Drug Saf 1997 6 Suppl 3 79 90 15073758
8. To err is human. Building a safer health system. LT Kohn JM Corrigan MS Donaldson Eds, Washington, Institute of Medicine: National Academy Press 1999 312
9. The impact of computerized physician order entry on medication error prevention. DW Bates JM Teich J Lee D Seger GJ Kuperman N Ma'Luf D Boyle L Leape, J Am Med Inform Assoc 1999 6 313 321 10.1136/jamia.1999.00660313 10428004 (Pubitemid 29328569)
10. Effects of computerized physician order entry and clinical decision support systems on medication safety. R Kaushal KG Shojania DW Bates, Arch Intern Med 2003 163 1409 1416 10.1001/archinte.163.12.1409 12824090 (Pubitemid 36758913)
11. Computer physician order entry: benefits, costs, and issues. GJ Kuperman RF Gibson, Ann Intern Med 2003 139 31 39 12834316 (Pubitemid 38124617)
12. The future of pharmacovigilance: a personal view. IR Edwards, Eur J Clin Pharmacol 2008 64 173 181 10.1007/s00228-007-0435-9 18172624
13. The Nordic countries as a cohort for pharmacoepidemiological research. K Furu B Wettermark M Andersen JE Martikainen AB Almarsdottir HT Sørensen, Basic Clin Pharmacol Toxicol 2010 106 86 94 10.1111/j.1742-7843.2009.00494.x 19961477
14. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. S Johansson MA Wallander FJ de Abajo LA García Rodríguez, Drug Saf 2010 33 223 232 10.2165/11319010- 000000000-00000 20158286
15. Using electronic health information for pharmacovigilance: the promise and the pitfalls. K Rosati, J Health Life Sci Law 2009 2 173 239
16. Underreporting of adverse drug reactions: Attitudes of Irish doctors. D Williams J Feely, Irish Journal of Medical Science 1999 168 257 261 10.1007/BF02944353 10624366 (Pubitemid 30021200)
17. Suspected adverse drug events requiring emergency department visits or hospital admissions. R Raschetti M Morgutti F Menniti-Ippolito A Belisari A Rossignoli P Longhini C La Guidara, European Journal of Clinical Pharmacology 1999 54 959 963 10.1007/s002280050582 10192758 (Pubitemid 29104418)
18. Adverse-drug-reaction related admissions to a hospital in Scotland. Y Hopf M Watson D Williams, Pharmacy World & Science 2008 30 854 862 10.1007/s11096-008-9240-5 21615857
19. Uses of routine data sets in the evaluation of health promotion interventions: opportunities and limitations. R Kane K Wellings C Free J Goodrich, Health Education 2000 100 33 41 10.1108/09654280010309030
20. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. LI Solberg JS Hurley MH Roberts WW Nelson FJ Frost AL Crain MJ Gunter LR Young, Am J Manag Care 2004 10 753 759 15623265 (Pubitemid 39518521)
21. Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. P Waller M Shaw D Ho S Shakir S Ebrahim, British Journal of Clinical Pharmacology 2004 59 213 219 (Pubitemid 40208858)
22. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. TY Wu MH Jen A Bottle M Molokhia P Aylin D Bell A Majeed, J R Soc Med 2010 103 239 250 10.1258/jrsm.2010.100113 20513902
23. Using ICD-9-CM codes in hospital claims data to detect adverse events in patient safety surveillance. P Hougland J Nebeker S Pickard M Van Tuinen C Masheter S Elder S Williams W Xu, Advances in patient safety: new directions and alternative approaches (Vol 1: Assessment) Rockville (MD): Agency for Healthcare Research and Quality, Battles JB, Keyes MA, Grady ML, 2008
24. Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data. J Stausberg J Hasford, Dtsch Arztebl Int 2010 107 23 29 20140170
25. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. DW Bates DJ Cullen N Laird LA Petersen SD Small D Servi S Laffel BJ Sweitzer BF Seha R Hallisey M van der Vliet R Nemeskal LL Leape for the ADE Prevention Study Group, JAMA 1995 274 29 34 10.1001/jama.274.1.29 7791255
26. Adverse drug events and medication errors: detection and classification methods. T Morimoto TK Gandhi AC Seger TC Hsieh DW Bates, Qual Saf Health Care 2004 13 306 314 10.1136/qshc.2004.010611 15289635 (Pubitemid 39070900)
27. International drug monitoring: the role of national centers. WHO, Technical Report Series No 498 Geneva: World Health Organisation 1972
28. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. M Zhang CDAJ Holman DB Preen K Brameld, Br J Clin Pharmacol 2006 63 163 170 (Pubitemid 46072102)
29. Developing indicators of inpatient drug events through nonlinear analysis using administrative data. JR Nebeker PR Yarnold RC Soltysik BC Sauer S Sims MH Samore RW Rupper KM Swanson LA Saritz J Shingle X Wu, Medical Care 2007 45 81 88 10.1097/MLR.0b013e3180616c2c
30. Allgemeine und Spezielle Kodierrichtlinien für die Verschlüsselung von Krankheiten und Prozeduren, Version 2006. Deutsche Krankenhausgesellschaft, Spitzenverbände der Krankenkassen, Verband der privaten Krankenversicherung, Institut für das Entgeltsystem im Krankenhaus, Institut für das Entgeltsystem im Krankenhaus 2005 [General and special standards for coding of diseases and procedures, version 2006] 21620992
31. How often are potential patient safety events present on admission? RL Houchens A Elixhauser PS Romano, The Joint Commission Journal on Quality and Patient Safety 2008 34 154 163
32. Trends in hospital admissions for adverse drug reactions in England: analysis of national episode statistics 1998-2005. H Patel D Bell M Molokhia J Srishanmuganathan M Patel J Car A Majeed, BMC Clinical Pharmacology 2007 7 9 17894876
33. Agenda Patientensicherheit 2007. Aktionsbündnis Patientensicherheit, Hrsg, 2007 Witten [Agenda Patient Safety 2007]
34. Adverse drug reaction-related hospitalizations: a nationwide study in The Netherlands. CS van der Hooft MC Sturkenboom K van Grootheest HJ Kingma BH Stricker, Drug Safety 2006 29 161 168 10.2165/00002018-200629020-00006 16454543 (Pubitemid 43213889)
35. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. TA Brennan LL Leape NM Laird L Hebert AR Localio AG Lawthers JP Newhouse PC Weiler HH Hiatt, NEJM 1991 324 370 376 10.1056/NEJM199102073240604 1987460
36. Agenda Patientensicherheit 2008., Schrappe M, Lessing C, Schmitz A, Conen D, Hart D, Hoppe-Tichy T, Jonitz G, Lauterberg J, Leppin G, Lichte T, Loskillet H, 2008 Witten [Agenda Patient Safety 2008]
37. Computerized surveillance of adverse drug events in hospital patients. DC Classen SL Pestotnik RS Evans JP Burke, JAMA 1991 266 2847 2851 10.1001/jama.266.20.2847 1942452
38. The pre-therapeutic classification of co-morbidity in chronic disease. AR Feinstein, J Chron Dis 1970 23 455 468 10.1016/0021-9681(70)90054-8
39. Relating patient characteristics at the time of admission to outcomes of hospitalization. P Pompei ME Charlson K Ales CR MacKenzie M Norton, J Clin Epidemiol 1991 44 1063 1069 10.1016/0895-4356(91)90008-W 1940999
40. Defining comorbidity: implications for understanding health and health services. JM Valderas B Starfield B Sibbald C Salisbury M Roland, Ann Fam Med 2009 7 357 363 10.1370/afm.983 19597174
41. Adverse drug reactions: definitions, diagnoses, and management. IR Edwards JK Aronson, Lancet 2000 356 1255 1259 10.1016/S0140-6736(00)02799-9 11072960
42. Strategies for detecting adverse drug events among older persons in the ambulatory setting. TS Field JH Gurwitz LR Harrold JK Rothschild K Debellis AC Seger LS Fish L Garber M Kelleher DW Bates, J Am Med Inform Assoc 2004 11 492 498 10.1197/jamia.M1586 15299000 (Pubitemid 39421733)
43. Assessing quality using administrative data. LI Iezzoni, Annals of Internal Medicine 1997 127 666 674 9382378
44. Study of the quality of codification of diagnoses and procedures under DRG conditions [in German]. B Klaus A Ritter H Groe Hülsewiesche B Beyrle HU Euler H Fender M Hübner G von Mittelstaedt, Gesundheitswesen 2005 67 9 19 15672301 (Pubitemid 40254875)
45. Frequency of hospital-acquired pneumonia in electronic and paper-based patient record. J Stausberg A Azaouagh, eHealth: Beyond the Horizon - Get IT There - Proceedings of MIE2008 - The XXIst International Congress of the European Federation for Medical Informatics Amsterdam: IOS Press, Andersen SK, Klein GO, Schulz S, Aarts J, Mazzolenie MC, 2008 470 483
46. Frequency of decubitus ulcer in patients of a university medical center. Combination of routine documentation and cross-sectional study [in German]. J Stausberg K Kröger I Maier W Niebel S Schneider, DMW 2005 130 2311 2315 10.1055/s-2005-918568 (Pubitemid 41501136)
47. Quality of coding in acute inpatient care [in German]. J Stausberg, Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2007 50 1039 1046 10.1007/s00103-007-0296-5